Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1700157	重组胰高血糖素样肽-1-Fc融合蛋白注射液		Injection	Biological Products(1)	New Drug Application	2018-04-04	成都金凯生物技术有限公司	Chengdu Jinkai Biotech Co Ltd	Certificate Issued	2018-10-08	view
CXSL1700159	重组胰高血糖素样肽-1-Fc融合蛋白注射液		Injection	Biological Products(7)	New Drug Application	2018-04-04	成都金凯生物技术有限公司	Chengdu Jinkai Biotech Co Ltd	Certificate Issued	2018-10-08	view
CXSL1700158	重组胰高血糖素样肽-1-Fc融合蛋白注射液		Injection	Biological Products(7)	New Drug Application	2018-04-04	成都金凯生物技术有限公司	Chengdu Jinkai Biotech Co Ltd	Certificate Issued	2018-10-08	view
CXSL1600132	重组人促卵泡激素-CTP融合蛋白注射液		Injection	Biological Products(7)	New Drug Application	2017-04-27	成都金凯生物技术有限公司	Chengdu Jinkai Biotech Co Ltd	Certificate Issued	2018-06-08	view
CXSL1600133	重组人促卵泡激素-CTP融合蛋白注射液		Injection	Biological Products(7)	New Drug Application	2017-04-27	成都金凯生物技术有限公司	Chengdu Jinkai Biotech Co Ltd	Certificate Issued	2018-06-08	view
CXSL1500121	注射用重组人甲状旁腺素(1-34)[56.5μg]	parathyroid hormone	Lyophilized	Biological Products(7)	New Drug Application	2016-07-11	成都金凯生物技术有限公司	Chengdu Jinkai Biotech Co Ltd	Certificate Issued	2017-02-21	view
CXSL1300095	重组抗CD20单克隆抗体注射液		Injection	Biological Products(2)	New Drug Application	2013-12-27	成都金凯生物技术有限公司	Chengdu Jinkai Biotech Co Ltd	Certificate Issued	2016-12-30	view
CXSL1300094	重组抗CD20单克隆抗体注射液		Injection	Biological Products(2)	New Drug Application	2013-12-27	成都金凯生物技术有限公司	Chengdu Jinkai Biotech Co Ltd	Certificate Issued	2016-12-30	view